Applications, hearings, determinations, etc.: Eli-Elsohly Laboratories, Inc.,

Text

---

Federal Register: October 29, 2003 (Volume 68, Number 209)NoticesPage 61699From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr29oc03-59

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By notice dated June 6, 2003, and published in the Federal Register on June 19, 2003, (68 FR 36844), Eli-Elsohly Laboratories, Inc., Mahmoud A. Elsohly, Ph.D., 5 Industrial Park Drive, Oxford, Mississippi 38655, made application by renewal to the Drug Enforcement Administration to be registered as a bulk manufacturer of the basic classes of Schedules I and II controlled substances listed below:

Drug

Schedule

Tetrahydrocannabinols (7370)............... I Dihydromorphine (9145)..................... I Codeine (9050)............................. II Amphetamine (1100)......................... II Methamphetamine (1105)..................... II Cocaine (9041)............................. II Codeine (9050)............................. II Dihydrocodeine (9120)..................... II Oxycodone (9143).......................... II Hydromorphone (9150)...................... II Benzoylecognine (9180).................... II Hydrocodone (9193)........................ II Morphine (9300)........................... II

The firm plans to manufacture non-deuterated controlled substances for use as analytical standards and deuterated controlled substances for use as internal standards.

No comments or objections have been received. DEA has considered the factors in title 21, United States Code, section 823(a) and determined that the registration of Eli-Elsohly Laboratories, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Eli-Elsohly Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.

Dated: October 15, 2003. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 03-27243 Filed 10-28-03; 8:45 amBILLING CODE 4410-09-M

---